Treatment of Neuromyelitis Optica Spectrum Disorders
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune central nervous system (CNS) inflammatory disorder that can lead to serious disability and mortality. Females are predominantly affected, including those within the reproductive age. Most patients develop relapsing attacks of optic neur...
Main Authors: | Koon-Ho Chan, Chi-Yan Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8638 |
Similar Items
-
The Immunology of Neuromyelitis Optica—Current Knowledge, Clinical Implications, Controversies and Future Perspectives
by: Michalina Jasiak-Zatonska, et al.
Published: (2016-03-01) -
Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder
by: Barbara Uzonyi, et al.
Published: (2021-04-01) -
NEUROMYELITIS OPTICA SPECTRUM DISORDERS: DIAGNOSIS AND TREATMENT, THE EXPERIENCE OF CLINICAL OBSERVATIONS
by: V. D. Piven, et al.
Published: (2018-12-01) -
Neuromyelitis optica: a pilot study of clinical presentation and status of serological biomarker AQP4 among patients admitted to a tertiary centre in NCNS, Sudan
by: Etedal Ahmed AbuElbasher Ibrahim, et al.
Published: (2020-02-01) -
Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes
by: Marco A. Lana-Peixoto, et al.
Published: (2019-06-01)